Clinical research results for Kelun-Biotech’s TROP2 ADC sacituzumab tirumotecan (sac-TMT) published in Nature Medicine, a top international medical journal BioSpace Nawigacja wpisu Tackling vulnerabilities in the supply chain of radiopharmaceuticals in the EU – European Medicines Agency Should You Join This Medical Technology Effort? – Medscape
